A patient calls at 3:00 AM to report that their infusion pump stopped working.
That single message can trigger a complaint file, a CAPA, a regulatory reportability decision, and months of downstream documentation.
Multiply that by every site in a clinical trial, every SOP revision, every supplier qualification file, every adverse event report moving between sponsors, CROs, sites, and regulators.
The document volume in life sciences isn’t the problem. The problem is that almost none of it can be safely handed to an AI model, because it contains Personally Identifiable Information (PII) or Protected Health Information (PHI): patient names, dates of birth, medical record numbers, investigator details, proprietary design data.
So the real question isn’t “can AI help life sciences companies.” It obviously can.
How do you let AI touch regulated data without exposing it?
Pensato was built to sit exactly there, as a secure intelligence layer between the systems of record (Veeva, Medidata, SharePoint, QMS, CTMS, email) and whatever model does the reasoning.
Here is what that looks like on a real document:
A Contract Research Organization (CRO) receives an investigator document by email. Pensato identifies it, detects PHI and PII, and swaps every sensitive field for redaction and/or a secure token before anything reaches a model. It run as local AI on infrastructure the organization controls. Only then does a local LLM read the sanitized version to determine what it is (an FDA Form 1572, tied to a specific study and site), check it for completeness, and flag that a required field is missing and an investigator’s CV has expired.
Pensato drafts the exception, assigns the follow up, and routes it for human review. A person makes the actual decision and the system keeps the audit trail. Nothing sensitive was ever exposed to a public LLM, and the original identifiers are only rehydrated inside the customer’s own environment.
That pattern repeats across the vertical: Trial Master File completeness checks, regulatory submission assembly, quality management workflows, adverse event intake, contract terms extraction. In every case, the AI does the reading and the routing, and a person still makes the call that matters.
This is the part of AI adoption in life sciences that is available.
A governed, secure way to let the AI tools your teams already want to use touch the documents they are not currently allowed to touch, without the exposure that has kept most of this locked down.
Bring Secure AI Into Focus
If you know someone in clinical operations, regulatory affairs, or quality at a CRO, medtech, or biotech company who has been asking “how do we actually do this safely,” this is worth forwarding to them.
Full breakdown of how this applies to each side of the business:
— Pensato for Life Sciences & MedTech